These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Obese Hypertensive Men Have Lower Circulating Proatrial Natriuretic Peptide Concentrations Despite Greater Left Atrial Size. Asferg CL, Andersen UB, Linneberg A, Goetze JP, Jeppesen JL. Am J Hypertens; 2018 May 07; 31(6):645-650. PubMed ID: 29471357 [Abstract] [Full Text] [Related]
3. Metabolic rather than body composition measurements are associated with lower serum natriuretic peptide concentrations in normal weight and obese men. Asferg CL, Nielsen SJ, Andersen UB, Linneberg A, Møller DV, Hedley PL, Christiansen M, Gøtze JP, Jeppesen JL. Am J Hypertens; 2014 Apr 07; 27(4):620-7. PubMed ID: 24025723 [Abstract] [Full Text] [Related]
6. Serum proatrial natriuretic peptide does not increase with higher systolic blood pressure in obese men. Asferg CL, Andersen UB, Linneberg A, Hedley PL, Christiansen M, Goetze JP, Jeppesen JL. Heart; 2017 Jan 15; 103(2):154-158. PubMed ID: 27496822 [Abstract] [Full Text] [Related]
7. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes. Theilade S, Hansen TW, Goetze JP, Rossing P. Am J Hypertens; 2015 Jun 15; 28(6):772-9. PubMed ID: 25468806 [Abstract] [Full Text] [Related]
9. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke. Fischer M, Katan M, Morgenthaler NG, Seiler M, Müller B, Lackner P, Errath M, Helbok R, Pfausler B, Beer R, Schmutzhard E, Broessner G. Cerebrovasc Dis; 2014 Jun 15; 37(2):128-33. PubMed ID: 24481415 [Abstract] [Full Text] [Related]
10. Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans. Zois NE, Terzic D, Færch K, Plomgaard P, Hansen JS, Rossing P, Goetze JP. EBioMedicine; 2017 Mar 15; 17():88-94. PubMed ID: 28262549 [Abstract] [Full Text] [Related]
11. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD. Bernasconi M, Tamm M, Bingisser R, Miedinger D, Leuppi J, Müller B, Christ-Crain M, Stolz D. Chest; 2011 Jul 15; 140(1):91-99. PubMed ID: 21106656 [Abstract] [Full Text] [Related]
12. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Metry G, Hall C, Wikström B, Källskog V, Hansell P, Danielson B. Acta Physiol Scand; 2001 Feb 15; 171(2):117-22. PubMed ID: 11350271 [Abstract] [Full Text] [Related]
15. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia. Masiá M, Papassotiriou J, Morgenthaler NG, Hernández I, Shum C, Gutiérrez F. Clin Chem; 2007 Dec 15; 53(12):2193-201. PubMed ID: 17951293 [Abstract] [Full Text] [Related]
16. NT-proANP and BNP in renovascular and in severe and mild essential hypertension. Mussalo H, Vanninen E, Ikäheimo R, Hartikainen J. Kidney Blood Press Res; 2003 Dec 15; 26(1):34-41. PubMed ID: 12697975 [Abstract] [Full Text] [Related]
18. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study. Daniels LB, Clopton P, Potocki M, Mueller C, McCord J, Richards M, Hartmann O, Anand IS, Wu AH, Nowak R, Peacock WF, Ponikowski P, Mockel M, Hogan C, Filippatos GS, Di Somma S, Ng L, Neath SX, Christenson R, Morgenthaler NG, Anker SD, Maisel AS. Eur J Heart Fail; 2012 Jan 15; 14(1):22-31. PubMed ID: 22140234 [Abstract] [Full Text] [Related]